| Cytokines in clinical cancer immunotherapy P Berraondo, MF Sanmamed, MC Ochoa, I Etxeberria, MA Aznar, ... British journal of cancer 120 (1), 6-15, 2019 | 1031 | 2019 |
| Evolving synergistic combinations of targeted immunotherapies to combat cancer I Melero, DM Berman, MA Aznar, AJ Korman, JLP Gracia, J Haanen Nature Reviews Cancer 15 (8), 457-472, 2015 | 720 | 2015 |
| Cancer immunotherapy with immunomodulatory anti-CD137 and anti–PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells AR Sánchez-Paulete, FJ Cueto, M Martínez-López, S Labiano, ... Cancer discovery 6 (1), 71-79, 2016 | 460 | 2016 |
| Tumor-produced interleukin-8 attracts human myeloid-derived suppressor cells and elicits extrusion of neutrophil extracellular traps (NETs) C Alfaro, A Teijeira, C Oñate, G Perez, MF Sanmamed, MP Andueza, ... Clinical Cancer Research 22 (15), 3924-3936, 2016 | 384 | 2016 |
| Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming ME Rodriguez-Ruiz, I Rodriguez, S Garasa, B Barbes, JL Solorzano, ... Cancer research 76 (20), 5994-6005, 2016 | 227 | 2016 |
| Intratumoral delivery of immunotherapy—act locally, think globally MA Aznar, N Tinari, AJ Rullán, AR Sánchez-Paulete, ME Rodriguez-Ruiz, ... The Journal of Immunology 198 (1), 31-39, 2017 | 222 | 2017 |
| An NK-like CAR T cell transition in CAR T cell dysfunction CR Good, MA Aznar, S Kuramitsu, P Samareh, S Agarwal, G Donahue, ... Cell 184 (25), 6081-6100. e26, 2021 | 219 | 2021 |
| Deciphering CD137 (4‐1BB) signaling in T‐cell costimulation for translation into successful cancer immunotherapy AR Sanchez‐Paulete, S Labiano, ME Rodriguez‐Ruiz, A Azpilikueta, ... European journal of immunology 46 (3), 513-522, 2016 | 146 | 2016 |
| A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity M Compte, SL Harwood, IG Muñoz, R Navarro, M Zonca, G Perez-Chacon, ... Nature communications 9 (1), 4809, 2018 | 128 | 2018 |
| Intratumor adoptive transfer of IL-12 mRNA transiently engineered antitumor CD8+ T cells I Etxeberria, E Bolaños, JI Quetglas, A Gros, A Villanueva, J Palomero, ... Cancer Cell 36 (6), 613-629. e7, 2019 | 116 | 2019 |
| Immunotherapeutic effects of intratumoral nanoplexed poly I: C MA Aznar, L Planelles, M Perez-Olivares, C Molina, S Garasa, I Etxeberría, ... Journal for immunotherapy of cancer 7 (1), 1-16, 2019 | 114 | 2019 |
| Virotherapy with a semliki forest virus–based vector encoding IL12 synergizes with PD-1/PD-L1 blockade JI Quetglas, S Labiano, MA Aznar, E Bolanos, A Azpilikueta, I Rodriguez, ... Cancer immunology research 3 (5), 449-454, 2015 | 106 | 2015 |
| Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells B Aldaz, A Sagardoy, L Nogueira, E Guruceaga, L Grande, JT Huse, ... PloS one 8 (10), e77098, 2013 | 89 | 2013 |
| Downregulation of FOXP1 is required during germinal center B-cell function A Sagardoy, JI Martinez-Ferrandis, S Roa, KL Bunting, MA Aznar, ... Blood, The Journal of the American Society of Hematology 121 (21), 4311-4320, 2013 | 84 | 2013 |
| Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice C Vicente-Dueñas, L Fontán, I Gonzalez-Herrero, I Romero-Camarero, ... Proceedings of the National Academy of Sciences 109 (26), 10534-10539, 2012 | 83 | 2012 |
| Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) costimulation A Teijeira, S Labiano, S Garasa, I Etxeberria, E Santamaría, A Rouzaut, ... Cancer immunology research 6 (7), 798-811, 2018 | 76 | 2018 |
| Intratumoral nanoplexed poly I: C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors I Márquez-Rodas, F Longo, ME Rodriguez-Ruiz, A Calles, S Ponce, ... Science Translational Medicine 12 (565), eabb0391, 2020 | 68 | 2020 |
| Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism S Labiano, A Palazón, E Bolanos, A Azpilikueta, AR Sánchez-Paulete, ... Oncoimmunology 5 (1), e1062967, 2016 | 59 | 2016 |
| Successful immunotherapy against a transplantable mouse squamous lung carcinoma with anti–PD-1 and anti-CD137 monoclonal antibodies A Azpilikueta, J Agorreta, S Labiano, JL Pérez-Gracia, ... Journal of Thoracic Oncology 11 (4), 524-536, 2016 | 53 | 2016 |
| CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell–Relevant Genes MA Aznar, S Labiano, A Diaz-Lagares, C Molina, S Garasa, A Azpilikueta, ... Cancer immunology research 6 (1), 69-78, 2018 | 43 | 2018 |
